Search Result "PDK inhibition."
Inhibition of Pyruvate Dehydrogenase Kinase as a Therapeutic Strategy against Cancer
Journal: Current Topics in Medicinal Chemistry
Volume: 18 Issue: 6 Year: 2018 Page: 444-453
Author(s): Swatishree Sradhanjali,Mamatha M. Reddy
Increase in Cisplatin Resistance by MeCP2 in Human Gastric Cancer through the Activation of the AKT Pathway by Facilitating PDK-1 Transcription
Journal: Current Cancer Drug Targets
Volume: 22 Issue: 5 Year: 2022 Page: 414-425
Author(s):
Pyruvate Dehydrogenase Kinases in the Nervous System: Their Principal Functions in Neuronal-glial Metabolic Interaction and Neuro-metabolic Disorders
Journal: Current Neuropharmacology
Volume: 10 Issue: 4 Year: 2012 Page: 393-403
Author(s): Mithilesh Kumar Jha,Sangmin Jeon,Kyoungho Suk
Ellagic Acid Inhibits VEGF/VEGFR2, PI3K/Akt and MAPK Signaling Cascades in the Hamster Cheek Pouch Carcinogenesis Model
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14 Issue: 9 Year: 2014 Page: 1249-1260
Author(s): Jaganathan Kowshik,Hemant Giri,Tanagala Kranthi Kiran Kishore,Rushendhiran Kesavan,Raju Naik Vankudavath,Geereddy Bhanuprakash Reddy,Madhulika Dixit,Siddavaram Nagini
Energetic Metabolic Roles in Pulmonary Arterial Hypertension and Right Ventricular Remodeling
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 3 Year: 2016 Page: 4780-4795
Author(s): Rui Zhang, Zhi-Cheng Jing
Targeted Inhibition of AKT in Pancreatic Cancer
Journal: Current Cancer Therapy Reviews
Volume: 5 Issue: 4 Year: 2009 Page: 288-295
Author(s): Tawnya L. Bowles, Colin Parsons, Diego J. Muilenburg, Richard J. Bold
Involvement of PI3K/Akt Pathway in Prostate Cancer - Potential Strategies for Developing Targeted Therapies
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 5 Issue: 1 Year: 2005 Page: 1125-1132
Author(s): Nicole Pommery, Jean-Pierre Henichart
Inhibition of mTOR Signaling by Quercetin in Cancer Treatment and Prevention
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13 Issue: 7 Year: 2013 Page: 1025-1031
Author(s): Ansgar Bruning
Glycolysis Inhibition as a Strategy for Hepatocellular Carcinoma Treatment?
Journal: Current Cancer Drug Targets
Volume: 19 Issue: 1 Year: 2019 Page: 26-40
Author(s): A.P. Alves,A.C. Mamede,M.G. Alves,P.F. Oliveira,S.M. Rocha,M.F. Botelho,C.J. Maia
PI3K/Akt/mTOR Pathway Inhibitors in Cancer: A Perspective on Clinical Progress
Journal: Current Medicinal Chemistry
Volume: 17 Issue: 3 Year: 2010 Page: 4326-4341
Author(s): P. Wu, Y.-Z. Hu